Investcorp, a global provider and manager of alternative investment products, completed the acquisition of Sanos Group, a provider of specialized clinical trial services to the global pharmaceutical and biotechnology industry. Financial terms were not disclosed. “Sanos has established itself as the partner of choice for pharma and biotech companies looking to conduct clinical trials for osteoarthritis, a condition for which there is currently a very high unmet medical need given the large and growing population of people being affected by it and the fact that there is no cure for it at the moment. Leveraging its strong OA franchise, we believe that Sanos has significant potential for international expansion through new research clinics in the US -the largest market for clinical trials- and other European countries beyond Denmark. We look forward to partnering with Sanos’ experienced management team to realize the opportunities ahead,” Daniel Lopez-Cruz, Investcorp Head of Private Equity in Europe.